Chlamydia trachomatis prevalence in men in the mid-west of Ireland

Sexually Transmitted Infections

Volumn 80, Issue 5, 2004, Pages 349-353

  Powell, J ^a   O'Connor, C ^a   O'hlarlaithe M ^a   Saunders, J ^b   De Freitas, J ^a  

^a UNIVERSITY HOSPITAL LIMERICK   (Ireland)

^b UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONDOM; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DYSURIA; HUMAN; INFORMED CONSENT; IRELAND; LABORATORY DIAGNOSIS; LIGASE CHAIN REACTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALITY; SMOKING; URINALYSIS; COHORT ANALYSIS; COST BENEFIT ANALYSIS; ECONOMICS; MASS SCREENING; METHODOLOGY; ORGANIZATION AND MANAGEMENT;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COHORT STUDIES; COST-BENEFIT ANALYSIS; HUMANS; IRELAND; MALE; MASS SCREENING; PREVALENCE; RISK FACTORS;

EID: 6044274734     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2003.008615     Document Type: Article

References (22)

1. Fenton KA. Screening men for Chlamydia trachomatis infection: have we fully explored the possibilities? Commun Dis Public Health 2000;3:86-9.
2. Peeling RW, Brunham RC. Chlamydiae as pathogens: new species and new issues. Emerg Inf Dis 1996;2:307-19.
3. Tait A, Hart CA. Chlamydia trachomatis in non-gonococcal urethritis patients and their heterosexual partners: routine testing by polymerase chain reaction. Sex Trans Infect 2002;78:286-8.
4. Scholes D, Stergachis A, Heidrick FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydia infection. N Engl J Med 1996;334:1362-6.
5. Kamwendo F, Forslin L, Bodin I, et al. Decreasing incidences of gonorrhoea- and chlamydia-associated acute pelvic inflammatory disease. A 25 year study from urban area of central Sweden. Sex Transm Dis 1996;23:384-91.
6. Pimenta J, Fenton KA. Recent trends in Chlamydia trachomatis in the United Kingdom and the potential for national screening. Eurosurveillance 2000;9:81-4.
7. Tobin JM, Harindra V, Tucker LJ. The future of chlamydia screening. Sex Transm Infect 2000;76:233-4.
8. Gene M, Ruusuvaara L, Mardh PA. An economic evaluation of screening for Chlamydia trachomatis in adolescent males. JAMA 1993;270;2057-64.
9. Marrazzo JM, Celum CL, Hillis SD, et al. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national chlamydia control strategy. Sex Transm Dis 1997;24:131-41.
10. Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med 1998;128:277-84.
11. Paavonen J. Is screening for Chlamydia trachomatis infection cost effective? Genitourin Med 1997;73:103-4.
12. Mardh A. A cost-effectiveness analysis of screening and treating for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996;124(Pt 1):1-7.
13. Pavoneen J, Poulakkainen M, Paukku M, et al. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening programme. Obstet Gynaecol 1998;92:292-8.
14. Stephenson JM. Screening for genital chlamydial infection. Br Med Bull 1998;54:891-902.
15. Anderson B, Olesen F, Møller JK, et al. Population-based strategies for outreach screening of urogenital Chlamydia trachomatis Infections: a randomised, controlled trial. Sex Transm Infect 2002;185:252-8.
16. Rogstad KE, Bates SM, Partridge S, et al. The prevalence of Chlamydia trachomatis infection in male undergraduates: a postal survey. Sex Transm Infect 2001;77:111-13.
17. Aldeen T, Haghdoost A, Hay P. Urine based screening for asymptomatic/undiagnosed genital chlamydial infection in young people visiting the accident and emergency department is feasible, acceptable, and can be epidemiologically helpful. Sex Transm Infect 2003;79:229-33.
18. Fenton KA, Johnson AM, McManus S, et al. Measuring sexual behaviour: methodological challenges in survey research. Sex Trans Infect 2001;77:84-92.
19. Hodgins S, Peeling RW, Dery S, et al. The value of mass screening for chlamydia control in high prevalence communities. Sex Trans Infect 2002;78(suppl 1):164-8.
20. Pierpoint T, Thomas B, Judd A. et al. Prevalence of Chlamydia trachomatis in young men in north west London. Sex Transm Infect, 2000;76:273-6.
21. Fenton KA, Korovessis C, Johnson AM, et al. Sexual behaviour in Britain: Reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 2001;358:1851-9.
22. Golden MR, Schillinger JA, Morkowitz L, et al. Duration of untreated genital infections with chlamydia trachomatis: a review of the literature. Sex Transm Dis 2000;27:329-37.